These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22812691)

  • 1. Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
    Nunes T; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Jan; 54(1):108-16. PubMed ID: 22812691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures.
    Perucca E; Elger C; Halász P; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsy Res; 2011 Sep; 96(1-2):132-9. PubMed ID: 21680153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.
    Johannessen Landmark C; Svendsen T; Dinarevic J; Kufaas RF; Reimers A; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI
    Ther Drug Monit; 2016 Aug; 38(4):499-505. PubMed ID: 27414974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study.
    Schmid E; Kuchukhidze G; Kirschner M; Leitinger M; Höfler J; Rohracher A; Kalss G; Wendling AS; Steinhoff BJ; Trinka E
    Acta Neurol Scand; 2017 Apr; 135(4):449-453. PubMed ID: 27444636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an enantioselective liquid-chromatography/tandem mass spectrometry method for the separation and quantification of eslicarbazepine acetate, eslicarbazepine, R-licarbazepine and oxcarbazepine in human plasma.
    Loureiro AI; Fernandes-Lopes C; Wright LC; Soares-da-Silva P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2611-8. PubMed ID: 21816689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.
    Mäkinen J; Rainesalo S; Peltola J
    Brain Behav; 2017 Mar; 7(3):e00634. PubMed ID: 28293474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
    Nunes T; Sicard E; Almeida L; Falcão A; Rocha JF; Brunet JS; Lefebvre M; Soares-da-Silva P
    Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and drug interactions of eslicarbazepine acetate.
    Bialer M; Soares-da-Silva P
    Epilepsia; 2012 Jun; 53(6):935-46. PubMed ID: 22612290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans.
    Almeida L; Soares-da-Silva P
    J Clin Pharmacol; 2004 Aug; 44(8):906-18. PubMed ID: 15286095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].
    Steinhoff BJ; Trinka E; Wendling AS
    Nervenarzt; 2011 Jun; 82(6):764-7. PubMed ID: 21052972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate--Expert opinion.
    Peltola J; Holtkamp M; Rocamora R; Ryvlin P; Sieradzan K; Villanueva V
    Epilepsy Behav; 2015 Sep; 50():46-9. PubMed ID: 26114438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy.
    Almeida L; Minciu I; Nunes T; Butoianu N; Falcão A; Magureanu SA; Soares-da-Silva P
    J Clin Pharmacol; 2008 Aug; 48(8):966-77. PubMed ID: 18508949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate.
    Maia J; Almeida L; Falcão A; Soares E; Mota F; Potgieter MA; Potgieter JH; Soares-da-Silva P
    Int J Clin Pharmacol Ther; 2008 Mar; 46(3):119-30. PubMed ID: 18397682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects.
    Almeida L; Nunes T; Sicard E; Rocha JF; Falcão A; Brunet JS; Lefebvre M; Soares-da-Silva P
    Acta Neurol Scand; 2010 Apr; 121(4):257-64. PubMed ID: 20047572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteers.
    Fontes-Ribeiro C; Macedo T; Nunes T; Neta C; Vasconcelos T; Cerdeira R; Lima R; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
    Drugs R D; 2008; 9(6):447-54. PubMed ID: 18989993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.
    Sunkaraneni S; Ludwig EA; Passarell JA; Blum D; Grinnell T; Fiedler-Kelly J
    J Clin Pharmacol; 2018 Jul; 58(7):927-938. PubMed ID: 29528499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of eslicarbazepine acetate in the mouse after oral administration.
    Alves G; Figueiredo I; Castel-Branco M; Lourenço N; Falcão A; Caramona M; Soares-da-Silva P
    Fundam Clin Pharmacol; 2008 Oct; 22(5):529-36. PubMed ID: 18710399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.